-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease, Including Asthma
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - #05 DEPRESSION
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 05: Depression and Other Mental Health
Disorders
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, M…
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Arthritis and Nontraumatic Joint Disease
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 01: Arthritis and Nontraumatic Joint
Disease
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - statement about not knowing
how long it takes for a cancer to spread from the ovary to
an advanced stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
December 19, 2016 - Disposition of Comments for CER 181 Mental Health Care
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2372
Published Online: December 19, 2016
Comparative Effectiveness Review Disposition of Comments Report
Research Revie…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - Treatment of Colorectal Cancer
The diagnosis of CRC requires pathologic review to
characterize and stage … I, 64.5 percent for stage IIA, 51.6 percent for stage
IIB, 32.3 percent for stage IIC, 74 percent for … IIIA,
45 percent for IIIB, 33.4 percent for IIIC, and 6 percent
for stage IV.9 Survival declines … with increasing depth of
tumor penetration, increasing tumor stage, and patient age. … Patients with stage
III colon cancer who received postsurgical FOLFOX
chemotherapy had a 3-year survival
-
effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
October 01, 2007 - methods, patient safety, pharmaceuticals, research, statistics
(Med Care 2007;45: S5–S8)
SETTING THE STAGE
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: June 12, 2013
Evidence-based Practice Center Systematic Review Protocol
Project Title: Menopausal Symptoms: Comparative
Effectiveness Review of Therapies
Original
Date
of
Protocol:
April
3,
2012
Amendment
Date:
June
5,
…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
October 01, 2011 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - detection
and treatment is ideal, only 15 percent of
lung cancer cases are diagnosed at an early
stage
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/measurement-and-outcomes-need-consensus-definitions-state-medicaid-programs-need-robust-hedis-and-ncqa-measures-for-all-severe-and-persistent-mental-health-conditions-consensus-definitions-would-help-answer-questions-such-as-
November 23, 2010 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
March 01, 2016 - detection
and treatment is ideal, only 15 percent of
lung cancer cases are diagnosed at an early
stage
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
January 01, 2006 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
May 07, 2010 - failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … the current search strategy and initial number of abstracts to be included in our abstract screening stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - It is refreshing to
see concerns of patient anxiety and quality of life sharing the stage
with the … That is, changes in therapeutic management or stage
reclassification are appropriate terminal points
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
June 01, 2010 - consultation with clinical experts may also identify
important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls
patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - Effectiveness was evident in
low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or
Gleason ²6) and … Hoskin, 201219 -- n = 218
EBRT: n = 108
EBRT + high-
dose-rate
brachytherapy
boost: n = 110
Stage … Effectiveness
was evident in low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or Gleason ²6)
and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - Effectiveness was evident in
low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or
Gleason ²6) and … Hoskin, 201219 -- n = 218
EBRT: n = 108
EBRT + high-
dose-rate
brachytherapy
boost: n = 110
Stage … Effectiveness
was evident in low-risk disease (PSA <10
ng/ml, stage ²T2a tumors, or Gleason ²6)
and
-
effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
May 19, 2010 - the cancer registry to identify patients diagnosed in 2006 with one of the following tumor types and stage … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … cancer (and Stage IIIB for lung cancer) disease in 2003-2005 who died 2-15 months after diagnosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are
well-positioned to diagnose early-stage … Full-text articles will be dually reviewed;
disagreements regarding inclusion at the full-text stage … comorbidities, we will determine whether studies report factors such as sex, duration of
the condition, and stage